Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?
about
Metformin and metabolic diseases: a focus on hepatic aspectsBeneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis.Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?Plasma levels of the arterial wall protein fibulin-1 are associated with carotid-femoral pulse wave velocity: a cross-sectional study.Additive relationship between serum fibroblast growth factor 21 level and coronary artery diseaseEffects of two weeks of metformin treatment on whole-body glycocalyx barrier properties in db/db mice.Metformin suppresses expression of the selenoprotein P gene via an AMP-activated kinase (AMPK)/FoxO3a pathway in H4IIEC3 hepatocytes.Nonalcoholic fatty pancreatic disease and cardio-metabolic risk: is there is a place for obstructive sleep apnea?Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism.Insulin sensitizers for the treatment of non-alcoholic fatty liver diseaseProbiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease.CNX-012-570, a direct AMPK activator provides strong glycemic and lipid control along with significant reduction in body weight; studies from both diet-induced obese mice and db/db mice models.Therapeutic effects of globular adiponectin in diabetic rats with nonalcoholic fatty liver disease.FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue-derived hormone levels in mouse models mimicking constipation-predominant IBS.Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease.Adipocytokine Regulation and Antiangiogenic Activity Underlie the Molecular Mechanisms of Therapeutic Effects of Phyllanthus niruri against Non-Alcoholic Fatty Liver Disease
P2860
Q28082736-A8F557A9-6006-4C7F-9D5D-642E0B2449D2Q30377409-47BBA6B7-FCB0-45AF-9376-044421BD0C74Q34501403-8515E94E-B283-4F98-8224-B004DE0A082EQ37042240-5124D25D-DA57-4F46-8259-B880E8ABB87AQ37153759-9B15E978-FB4D-4353-8042-31A4D7B24AE7Q37399864-AFEB79BB-7A40-435B-8593-685FC2863251Q37428656-61A2D5AC-78CE-433B-9F56-17BDCE24450EQ37539722-89FD1564-986D-4CF3-8FEF-03612602840FQ38192049-CA23F293-C1FB-49CD-99FD-06DAE899DB1FQ38209666-16EF135E-B20E-4CD6-858A-5617683E3B97Q38408904-BB3B206D-8DA5-4298-B90D-EE6D26262CF7Q41900013-FAD551AF-C870-40EC-8190-A67DE33DCAE4Q42961701-5B417C77-D27C-48C3-AEC2-9CA55C976822Q47265903-5F78CCE2-D1ED-47C0-8B46-05EA007F3CBFQ55379918-DFF2525B-18BB-4F7C-9A63-10A7E79D1A0AQ58792689-550252A7-EB8D-4C19-BC74-9762AF697FCE
P2860
Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Relation between augmentation ...... fects beyond glucose lowering?
@ast
Relation between augmentation ...... fects beyond glucose lowering?
@en
type
label
Relation between augmentation ...... fects beyond glucose lowering?
@ast
Relation between augmentation ...... fects beyond glucose lowering?
@en
prefLabel
Relation between augmentation ...... fects beyond glucose lowering?
@ast
Relation between augmentation ...... fects beyond glucose lowering?
@en
P2093
P2860
P50
P921
P356
P1476
Relation between augmentation ...... fects beyond glucose lowering?
@en
P2093
Dov Gavish
Elena Omelchenko
Marina Shargorodsky
Zipora Matas
P2860
P2888
P356
10.1186/1475-2840-11-61
P407
P577
2012-06-07T00:00:00Z
P5875
P6179
1032223439